Company Filing History:
Years Active: 2012-2017
Title: Innovations by Fabrice Béal in Medical Technology
Introduction
Fabrice Béal is a notable inventor based in Mutters, Austria. He has made significant contributions to the field of medical technology, particularly in the development of implantable electric leads. With a total of four patents to his name, Béal's work focuses on enhancing the safety and functionality of medical devices.
Latest Patents
Fabrice Béal's latest patents include innovative designs for impact protection in implantable electric leads. One of his patents describes an implantable electric lead arrangement that features parallel lead wires wound in an elongated helix around a central longitudinal axis. This design incorporates at least one support wire that has a higher strain energy absorption capacity than the lead wires, providing mechanical strength against external impact forces. Another patent outlines a conical shape lead core that is fixed and enclosed within the wire helix. This core is designed to provide impact strain relief by resisting radial and axial deformation from external forces, ensuring a smooth transition between protected and unprotected portions of the electric lead.
Career Highlights
Béal's career is marked by his dedication to improving medical implant systems. His innovative approaches have led to advancements that enhance the reliability and safety of medical devices used in various treatments. His work at Med-El Elektromedizinische Geräte GmbH has positioned him as a key player in the field of medical technology.
Collaborations
Fabrice Béal collaborates with talented professionals in his field, including Martin Zimmerling and Davide De Luca. These collaborations have fostered an environment of innovation and creativity, leading to the development of groundbreaking medical technologies.
Conclusion
Fabrice Béal's contributions to medical technology through his patents and collaborations highlight his commitment to advancing healthcare solutions. His innovative designs for implantable electric leads demonstrate the potential for improving patient outcomes in medical treatments.